NYSE American - Delayed Quote USD

Kairos Pharma, Ltd. (KAPA)

0.6200
-0.0001
(-0.02%)
At close: May 14 at 4:00:00 PM EDT
0.6282
+0.01
+(1.32%)
After hours: May 14 at 7:50:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
2,343
2,343
1,714
571
1,943
Operating Income
-2,343
-2,343
-1,714
-571
-1,943
Net Non Operating Interest Income Expense
-859
-859
-98
-479
-202
Other Income Expense
599
599
--
--
--
Pretax Income
-2,603
-2,603
-1,812
-1,050
-2,145
Net Income Common Stockholders
-2,603
-2,603
-1,812
-1,050
-2,145
Diluted NI Available to Com Stockholders
-2,603
-2,603
-1,812
-1,050
-2,145
Basic EPS
-0.23
--
-0.16
-0.10
-0.10
Diluted EPS
-0.23
--
-0.16
-0.10
-0.10
Basic Average Shares
11,356.4510
--
11,215.8070
10,839.4520
10,850.4100
Diluted Average Shares
11,356.4510
--
11,215.8070
10,839.4520
10,850.4100
Total Operating Income as Reported
-2,343
-2,343
-1,714
-571
-1,943
Total Expenses
2,343
2,343
1,714
571
1,943
Net Income from Continuing & Discontinued Operation
-2,603
-2,603
-1,812
-1,050
-2,145
Normalized Income
-3,202
-3,202
-1,812
-1,050
-2,145
Interest Expense
189
189
98
459
164
Net Interest Income
-859
-859
-98
-479
-202
EBIT
-2,414
-2,414
-1,714
-591
-1,981
EBITDA
-2,254
-2,254
-1,554
-431
-1,883
Reconciled Depreciation
160
160
160
160
98
Net Income from Continuing Operation Net Minority Interest
-2,603
-2,603
-1,812
-1,050
-2,145
Total Unusual Items Excluding Goodwill
599
599
0
--
--
Total Unusual Items
599
599
0
--
--
Normalized EBITDA
-2,853
-2,853
-1,554
-431
-1,883
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/16/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PCSA Processa Pharmaceuticals, Inc.
0.2340
+2.09%
 
ARTV Artiva Biotherapeutics, Inc.
1.8100
-11.71%
 
INAB IN8bio, Inc.
0.1467
-8.31%
 
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
 
TNFA TNF Pharmaceuticals, Inc.
0.2205
+23.39%
 
PTIX Protagenic Therapeutics, Inc.
3.2800
-6.55%
 
MTVA MetaVia Inc.
0.6670
+2.62%
 
CDT Conduit Pharmaceuticals Inc.
0.4000
+0.86%
 
KPRX Kiora Pharmaceuticals, Inc.
3.0866
-3.54%
 
QNRX Quoin Pharmaceuticals, Ltd.
7.65
+20.28%